Trade EVMN anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Evommune, Inc. (EVMN) is trading at US$12.17, up 1.42% today as of Sep 4, 13:10 EDT. The company has a market capitalisation of US$508.82M. Over the past 52 weeks, EVMN has traded between US$10.47 and US$33.20. On Syfe you can trade EVMN with $0 commission and add it to your watchlist.
| Previous close | US$12.00 |
|---|---|
| Market cap | US$508.82M |
| 52-week range | US$10.47 – US$33.20 |
| Volume | 594.08K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Evommune, Inc.
Evommune, Inc. is a clinical-stage biotechnology company. It engages in the development of medicines for inflammatory diseases. The company was founded by Luis C. Pena, Eugene Andrew Bauer, and Hans Hofland in 2020 and is headquartered in Palo Alto, CA.
Year: 2025
--HC Wainwright Downgrades Evommune to Neutral From Buy
Jun 30, 11:14 AM · MT Newswires
Top Midday Decliners
Jun 29, 5:49 PM · MT Newswires
Evommune's Trial of EVO756 Misses Primary Endpoint; Shares Tumble Pre-Bell
Jun 29, 1:00 PM · MT Newswires
Evommune, Inc. (EVMN) stock is trading at US$12.17, +1.42% from the previous close of US$12.00.
The market cap for Evommune, Inc. (EVMN) stock is approximately US$508.82M.
The 52-week high for Evommune, Inc. (EVMN) stock is US$33.20.
The 52-week low for Evommune, Inc. (EVMN) stock is US$10.47.
Evommune, Inc. (EVMN) does not currently pay a dividend.
Stay on top of EVMN
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
